Mazda selects Codebeamer ALM solution to help strengthen requirements management, improve quality, support compliance, and accelerate innovation for software-defined vehicle development Maintains connectivity to Mazda's advanced Model-Based Development (MBD) Establishes foundation for integrated product development and future AI-enabled workflows BOSTON, May 21, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Mazda Motor Corporation, a leading global automaker, has selected the PTC Codebeamer® Application Lifecycle Management (ALM) solution to support its software-defined vehicle development (SDV). Mazda will use Codebeamer to standardize requirements, testing, and validation, enabling end-to-end traceability and faster product development while meeting automotive standards.

PTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript

Free access to Onshape, Creo+, Codebeamer+, and a startup package for Arena to manage every stage of the product lifecycle from design and development through compliance and launch Annual renewals available to support startups through key funding and revenue milestones Exposure to PTC's global ecosystem to support industry visibility BOSTON , May 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the expansion of its startup program to companies across all industries, extending a model that began with its Aerospace and Defense Startup Program, launched in 2025. Building on that program's success, PTC for Startups now makes PTC's professional-grade product development tools available to qualifying early and growth-stage startups worldwide — at no cost.

Connects Printed Circuit Board (PCB) design from Altium directly into Onshape in a unified cloud-native workflow Eliminates file-based PCB data exchange between electrical and mechanical design Streamlines inclusion of detailed components in your personal or company library BOSTON, May 12, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced a new integration between its cloud-native Onshape® computer‑aided design (CAD) and product data management (PDM) platform and Altium. The connector enables electrical and mechanical engineering teams to collaborate more effectively by bringing Printed Circuit Board (PCB) designs directly into Onshape and keeping changes synchronized across both platforms.

PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model, anchored by the successful Sephience launch. Sephience's rapid commercial uptake is offsetting DMD franchise declines, with Q1 2026 product revenue up 47% year-over-year and strong patient onboarding momentum. PTCT's partnership with Novartis on votoplam for Huntington's disease offers de-risked late-stage upside, while a $1.9B cash position provides strategic flexibility and reduces near-term dilution risk.

PTC Therapeutics NASDAQ: PTCT reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.

– First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise –    – Global Sephience™ (sepiapterin) launch momentum continues with first quarter 2026 revenue of $125 million, representing 36% quarter-over-quarter growth – – Positive topline results from 24-month interim analysis of PIVOT-HD extension study of votoplam, supporting ongoing global Phase 3 INVEST-HD study and potential regulatory interactions – – Open-label vatiquinone registration study to be initiated in Q3 2026 based on FDA feedback – WARREN, N.J., May 7, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ended March 31, 2026.

PTC jumped in pre-market trading after fiscal Q2 2026 revenue rose 22% and AI-driven product demand fueled stronger ARR growth and buybacks.

PTC shares jumped 7.53% in after-hours trading after the company beat Q2 fiscal 2026 revenue estimates by 8.63% and EPS expectations by 33.83%.

PTC Inc. (PTC) Q2 2026 Earnings Call Transcript